Alison Rand
Analyst · SunTrust. Please go ahead
Thank you, Glenn and good morning everyone. As we turn to the Term Life segment on Slide seven, let me briefly review fourth quarter results and then provide insight into our 2020 expectations for the segment. In the fourth quarter, Term Life revenues were $319 million, an increase of 9% year-over-year driven by a 10% increase in adjusted direct premium. Operating income before income taxes grew 14% to $82 million. Looking at the individual elements of our Term Life segment, incurred claims were generally in line with the prior year as was the benefits in claims ratio at 57.7%. The DAC amortization ratio which is typically high in the fourth quarter due to seasonally weaker persistency was 16.4% for the quarter well below the prior year ratio of 17.1%. While there are several drivers of the DAC ratio, persistency is a noteworthy factor. After a period of weaker persistency in late 2016 and 2017, persistency stabilized in 2018 and throughout 2019 has improved to back to historical level. The fourth quarter shows the largest improvement to date versus the prior year. The insurance expense ratio for the quarter was 8%, higher than the 7.8% in the prior year period, but slightly lower than we had indicated last quarter. During the quarter, we trued up our segment allocation of information and cyber security expenses, which shifted some expenses on a full year basis out of Term Life. Company-wide insurance and other operating expenses were in line with our expectations for the quarter. I will discuss company-wide insurance and other operating expenses for the quarter as well as expectations for 2020, including a high-level view of segment allocation later in the call. Let's shift our discussion to Term Life projections for 2020, starting with a deeper dive into adjusted direct premium. As shown on Slide eight, adjusted direct premiums include direct first year, and direct renewal premiums on policies issued post IPO, direct premiums on policies issued pre-IPO and premium ceded to the IPO co-insurers. Each of these components have different growth drivers. Direct first year premiums are mainly driven by the number of policies issued each year, coupled with the size of those policies as well as additions and increase within premium primarily from our increasing benefit rider. Post IPO, direct renewal premiums grow each year from layering another year of sales on to the enforced premium base. We've often referred to this as the building back of our enforced block post IPO. Total post IPO direct premiums grew 12% in the aggregate in 2019. Pre-IPO direct renewal premiums have been declining about 3% per year as the closed block runs off. Historically, premiums ceded to the IPO co-insurers ran off at a similar rate, however, beginning in 2017 we stopped feeding premiums that reached the end of their initial level premium period, which accelerated the rate of decline to around 6%. The chart on the right side of this slide shows our growth expectations for adjusted direct premiums by component. First year premiums assume a hypothetical growth in issued policies per year of 3% combined with growth in premium edition from increasing benefit riders. Post IPO renewal premiums continue to grow, but at a diminishing rate as each block of new business added is smaller in comparison to the growing end force. We expect pre-IPO direct premiums to continue to run off at a rate of 3% annually and premium ceded to the IPO co-insurers to decrease at a rate trending toward 5% annually. Net, net for 2020, we expect adjusted direct premiums to grow by 9% and at a 3% annual growth in sales for the growth rate to decline by approximately 1% in both 2021 and 2022. Continuing with other aspects of Term Life performance, we do not foresee any significant changes in either the benefits and claims ratio or the DAC amortization ratio in 2020. But recall, that the growing block of increasing benefit riders generally have a lower DAC ratio and higher benefit ratio than newly issued business. Margin should remain in the mid-19% range but still allowing for investment in new technologies support of Term Life business. Turning now to our investments and savings products segment on slide nine, revenues of $182.7 million increased 11% year-over-year while income before income taxes increased 16% to $53 million. Sales-based revenues grew around 12% in line with growth in revenue generating product sales. Sales-based net revenues as a percentage of revenue generating product sales increased during the quarter reflecting a higher mix of annuity sales during the period. Asset based revenues grew 12% in line with growth and average client asset values, which benefited from strong sales and market conditions throughout 2019 as well as the recovery from the market pullback in the fourth quarter of 2018. Asset base net revenues as a percentage of average asset values were also higher in the quarter, benefiting from segregated fund DAC amortization that was about $2 million lower than historical levels due to favorable market performance as well as annual assumption setting for redemption. Rise in operating expenses in the segment was largely due to segment allocation revisions I discussed earlier. Moving to our corporate and other distributed products segment, adjusted operating revenues of $29.3 million declined 8% while benefits and expenses of $43.1 million rose 7%. The decrease in segment revenues reflects lower ancillary product income as well as lower net investment income as more NII is allocated to the Term Life segment to support growth in the block of business. On a company-wide basis, net, net investment income grew 3% driven by growth in the invested asset portfolio partially offset by lower overall yields. The increase in C&O benefits and expenses was driven by 2 million higher insurance and other operating expenses and a $1.7 million charge to write off amount ceded on a closed block of business to a reinsurer counterparty ordered into receivership. We have not ceded new business to this particular reinsurer in over 20 years. Let's turn now to slide 11 for a discussion of consolidated insurance and other operating expenses. During the fourth quarter, expenses increased 9% year-over-year to a total of $106.7 million which was in line with our expectations. The growth was driven by year-over-year increases in employee salaries and expenses that support the growth of our Term Life business. It also included around $3 million in higher costs related to various technology initiatives we've discussed throughout the year for a total incremental technology spend of $10 million in 2019. Looking forward to 2020, we anticipate insurance and other operating expenses will increase between $25 million and $30 million or 6% to 7% year-over-year. We expect total insurance and other operating expenses to be split about 45% to Term Life, 30% to IFC and 25% to corporate and other. As a reminder, first quarter expenses are generally about $10 million higher than other quarters due to the annual grant of management equity awards in February. Slide 12 shows the main components of expense growth. The first category includes expenses that are tied directly to a revenue source such as premium taxes, asset base fees and record keeping fees. The $4 million increase shown reflects the year-over-year savings of approximately $5 million in ISP [ph] from service provider contract changes and operational efficiencies we discussed in the past. Salaries and other employee related costs excluding those related to technology, which I'll discuss in a moment are expected to grow by approximately $6 million. The increase is due to a combination of annual merit increases, staffing increases and higher employee benefit cost. Technology costs are expected to increase by $8 million. Our priorities for the year include client and new rep engagement, Term Life sales process improvements, business intelligence and continued infrastructure modernization. Salaries and benefits for employees and contractors that are assigned to technology initiatives are included in this category. To enhance our revenue growth opportunity, we are investing in both new and existing product distribution. We are embarking on a multi-year expansion of our mortgage program, which is expected to add $3 million to 2020 costs. As Glenn mentioned earlier, we are adding a team of wholesalers to support our Term Life business and have included $2 million in this year's budget to support their efforts. Finally, we've added $2 million to cover require mailings and other implementation costs associated with the SEC’s REG BI and other potential regulatory changes. Let me wrap up with some holding company statistics on Slide 13. Our tax rate during the quarter was 23.4% and 23.2% for the full year which is consistent with our annual rate estimate. We expect the 2020 full year rate to be about 23.5%. Our corporate balance sheet remains strong with ample liquidity. As of December 31st, holding company liquidity is approximately $270 million and Primerica Life statutory risk-based capital ratio is estimated to be around 440%. We plan to continue to take ordinary dividends from Primerica Life to the extent available with the goal of maintaining our near-term RBC ratio in the low-to-mid 400% range. Operator, let's open the line-up for questions.